The aim of this study was to investigate the effects of in vivo and in vitro anoxia and reoxygenation on the oxidative phosphorylation of brain mitochondria and to study the protective effects of Ginkgo biloba extract (EGb 761). Cerebral ischemia and reperfusion induced slight decreases in respiration rates and in the efficiency of oxidative phosphorylation. Total protection of mitochondrial function was observed after chronic pretreatment of rat with EGb 761. On the contrary, in vitro anoxia and reoxygenation of isolated brain mitochondria during respiratory assay promoted important alteration in respiration rates (around -50%) and in the oxidative phosphorylation yield (-44%). Partial protection was observed after anoxia and reoxygenation in the presence of EGb 761. Such a difference between in vivo and in vitro results could be explained by an intracellular antioxidant pool that could protect mitochondria in vivo.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15376520490257455DOI Listing

Publication Analysis

Top Keywords

egb 761
16
oxidative phosphorylation
16
brain mitochondria
12
vivo vitro
12
anoxia reoxygenation
12
phosphorylation brain
8
vitro anoxia
8
respiration rates
8
protective egb
4
0
4

Similar Publications

Background/objectives: Previous research indicates that extract (Gbe) may contribute to slowing down the progression of dementia. This retrospective cohort study analyzed the association between Gbe prescriptions and the progression of dementia severity in a real-world setting.

Methods: This study was conducted using data from patients with an initial diagnosis of mild or moderate dementia between January 2005 and December 2022 from the IQVIA™ Disease Analyzer database.

View Article and Find Full Text PDF

Purpose: Myocardial infarction (MI) is a prevalent cardiovascular disorder affecting individuals worldwide. There is a need to identify more effective therapeutic agents to minimize cardiomyocyte damage and enhance cardioprotection. extract is extensively used to treat neurological disorders and peripheral vascular diseases.

View Article and Find Full Text PDF

Background: Dementia leads to cognitive decline affecting memory, thinking, and behavior. Current pharmaceutical treatments are symptomatic, with limited efficacy and significant drawbacks. Ginkgo biloba extract (EGb761) is being explored as an adjuvant therapy for dementia because of its potential neuroprotective effects.

View Article and Find Full Text PDF

Ginkgo biloba extract EGb 761® ameliorates cognitive impairment and alleviates TNFα response in 5xFAD Alzheimer's disease model mice.

Phytomedicine

January 2025

Department of Psychiatry and Psychotherapy, University Medical Center Mainz, Johannes Gutenberg-University Mainz, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center at the Johannes Gutenberg University Mainz, Mainz, Germany. Electronic address:

Background: Ginkgo biloba leaf extract EGb 761® has shown clinical efficacy in patients with mild cognitive impairment and dementia. However, the pharmacological action of EGb 761® in Alzheimer's disease (AD) remains unclear and molecular mechanisms targeted in the brain are not completely understood.

Hypothesis/purpose: We aimed to investigate 1) the potential sex-dependent effects of oral administration of EGb 761® in 5xFAD mice, an AD mouse model, and 2) the underlying microglial subtype responsible for the observed anti-inflammatory effects in the brain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!